BCMLT
MRNA icon

Beacon Capital Management LLC (Tennessee)’s Moderna MRNA Stock Holding History

Beacon Capital Management LLC (Tennessee)’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-27
Closed -$1.8K – 1159
2024
Q3 		$1.8K Hold
27
– – ﹤0.01% 1021
2024
Q2 		$3.21K Hold
27
– – ﹤0.01% 787
2024
Q1 		$2.88K Buy
+27
New +$2.72K ﹤0.01% 809

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Beacon Capital Management LLC (Tennessee)'s MRNA Position: Q4 2024 in Review

Beacon Capital Management LLC (Tennessee) sold out of Moderna (MRNA) in Q4 2024, closing a stake of 27 shares — an estimated $1.8K sold.

Beacon Capital Management LLC (Tennessee) first reported a position in MRNA in Q1 2024 and held it in 3 quarters. The position peaked at $3.21K in Q2 2024. 746 funds tracked by Wall St. Rank hold MRNA as of Q4 2024.

  • Beacon Capital Management LLC (Tennessee) reported no remaining Moderna position as of Q4 2024 after selling out during the quarter.
  • Beacon Capital Management LLC (Tennessee) sold 27 Moderna shares in Q4 2024, an estimated $1.8K.
  • Beacon Capital Management LLC (Tennessee) first reported a position in Moderna in Q1 2024 and held it in 3 quarters.
  • Beacon Capital Management LLC (Tennessee)'s Moderna position peaked at $3.21K in Q2 2024.
  • 746 funds tracked by Wall St. Rank held Moderna as of Q4 2024.

Based on Beacon Capital Management LLC (Tennessee)'s 13F filing for Q4 2024, filed 30 Jan 2025.